))
A Look Into the CEACAM 5 Biomarker
Manage episode 397584139 series 2794112
The Academy of Oncology Nurse & Patient Navigators, The Academy of Oncology Nurse, and Patient Navigators에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 The Academy of Oncology Nurse & Patient Navigators, The Academy of Oncology Nurse, and Patient Navigators 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
To close out this 3-part series, Terri Conneran, founder of KRAS (Knowledge + Research + Advocacy = Survivorship) Kickers, Jennifer Aversano, MSN, RN, OCN, ONN-CG, a lung nurse navigator at Northwest Community Hospital, and Claudia Miller, RN, ONC, ONN-CG, a thoracic oncology nurse navigator at Hollings Cancer Center, will explore the CEACAM 5 biomarker, clinical trial recruitment strategies deployed by navigators, and the role that shared decision-making has on patient outcomes throughout their treatment.
Thank you to our sponsor, Sanofi, for making this biomarker podcast series possible.
31 에피소드
공유
